CryoPort (CryoPort) Change in Organic Revenue % : -5.00% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is CryoPort Change in Organic Revenue %?

Organic revenue is revenue generated from within a company that is a direct result of the firm's existing operations. Change in Organic Revenue % provides management and investors with the level of revenue change that was generated from the sale of a company's products and services.

CryoPort's Change in Organic Revenue % for the quarter that ended in Dec. 2023 was -5.00% , which is higher than -7.10% for the pervious quarter ended in Sep. 2023.

CryoPort's Change in Organic Revenue % for the annual that ended in Dec. 2023 was -1.70% , which is lower than 3.20% for the pervious year ended in Dec. 2022.

The historical rank and industry rank for CryoPort's Change in Organic Revenue % or its related term are showing as below:

CYRX's Change in Organic Revenue % is not ranked ^*
in the Transportation industry.
Industry Median:
* Ranked among companies with meaningful Change in Organic Revenue % only.

CryoPort Change in Organic Revenue % Historical Data

The historical data trend for CryoPort's Change in Organic Revenue % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CryoPort Change in Organic Revenue % Chart

CryoPort Annual Data

Trend

Dec17

Dec22

Dec23

Change in Organic Revenue %

Get a 7-Day Free Trial

CryoPortQuarterly Data

Trend

Mar18

Jun18

Sep18

Mar19

Jun19

Sep19

Mar20

Jun20

Sep20

Mar21

Jun21

Sep21

Mar22

Jun22

Sep22

Dec22

Mar23

Jun23

Sep23

Dec23

Change in Organic Revenue %

Get a 7-Day Free Trial

Competitive Comparison of CryoPort's Change in Organic Revenue %

For the Integrated Freight & Logistics subindustry, CryoPort's Change in Organic Revenue %, along with its competitors' market caps and Change in Organic Revenue % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CryoPort (NAS:CYRX) Change in Organic Revenue % Explanation

Organic revenue is the product of the internal processes of a company and are generated solely within the firm minus cost of goods sold (COGS). It’s similar to the gross income. Organic revenue provides management and investors with the level of revenue that was generated from the sale of a company's products and services.

If the change in organic revenue is positive, then the company generates increases in organic revenue, which is typically referred to as organic growth. Once an acquisition is fully integrated into a company's existing operations, sales from the acquired unit or business would then be counted as organic sales.

Organic revenue is important because it doesn't include taxes and other one-off items that may skew a company's profit in a given year. The changing of the organic revenue also reflects the company’s core business profitability is increasing, especially when an acquisition happened. It is a more reliable index than gross income at that time because the performance of newly acquired businesses may change in the future.

CryoPort (CryoPort) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » Change in Organic Revenue %

Comparable Companies

Traded in Other Exchanges

CKX:Germany

Address

112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027

Website

https://www.cryoport.com

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Executives

Robert J Hariri	director	341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton	director, officer: President, CEO	C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman	director	305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich	officer: Chief Financial Officer
Mark W Sawicki	officer: Chief Scientific Officer	3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock	director	7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini	director	20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour	director	PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam	director	4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath	director	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p.	10 percent owner	C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154